## FFIV: F5, Inc. - XLK: Technology

### Executive Summary

No thesis match: MRS_20 0.2% below STRENGTH zone (4.0-10.0%); PEG 2.07 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-2.5% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($244.81)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bearish (Bullish: 0, Bearish: 10)

**1. F5, Inc. Securities Fraud Class Action Result of Data Breach and Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC**
- Source: PR Newswire | 20260103T030813 | Bearish | Relevance: 100%
- Kahn Swick & Foti, LLC (KSF) has reminded investors with substantial losses in F5, Inc. that they have until February 17, 2026, to file lead plaintiff applications in a securities class action lawsuit. This lawsuit alleges that F5 and its executives failed to disclose material information, including the impact of a security breach involving its BIG-IP product, leading to a significant stock decline. Investors who purchased F5 securities between October 28, 2024, and October 27, 2025, are encouraged to contact KSF to discuss their legal rights.

**2. ROSEN, LEADING INVESTOR COUNSEL, Encourages F5, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - FFIV**
- Source: GlobeNewswire | 20260102T192516 | Bearish | Relevance: 100%
- The Rosen Law Firm is encouraging F5, Inc. shareholders who purchased securities between October 28, 2024, and October 27, 2025, to secure legal counsel before the February 17, 2026, lead plaintiff deadline for a securities class action. The lawsuit alleges that F5 created a false impression about its revenue outlook and growth, minimizing risks, while facing a significant security incident. Rosen Law Firm, a global investor rights law firm, emphasizes its track record in securities class actions and encourages investors to choose qualified counsel.

**3. Portnoy Law Firm Announces Class Action on Behalf of F5, Inc. Investors**
- Source: GlobeNewswire | 20260102T150439 | Bearish | Relevance: 100%
- The Portnoy Law Firm announced a class action lawsuit on behalf of F5, Inc. (NASDAQ: FFIV) investors who purchased securities between October 28, 2024, and October 27, 2025. The lawsuit follows F5's disclosure of a cybersecurity incident involving unauthorized access to its systems, including its highest revenue product, which led to a sharp decline in share prices. Investors have until February 17, 2026, to file a lead plaintiff motion.

**4. Portnoy Law Firm Announces Class Action on Behalf of F5, Inc. Investors**
- Source: GlobeNewswire | 20260102T100200 | Bearish | Relevance: 100%
- The Portnoy Law Firm has announced a class action lawsuit on behalf of F5, Inc. (NASDAQ: FFIV) investors who purchased securities between October 28, 2024, and October 27, 2025. The lawsuit follows F5's disclosure of a major cybersecurity incident that impacted its highest revenue product, causing a sharp decline in share price. Investors have until February 17, 2026, to file a lead plaintiff motion.

**5. FFIV Shareholder Notice: F5, Inc. (FFIV) Faces Securities**
- Source: GlobeNewswire | 20260101T030824 | Bearish | Relevance: 100%
- A securities class action lawsuit has been filed against F5, Inc. (FFIV) on behalf of investors who purchased securities between October 28, 2024, and October 27, 2025. The lawsuit follows F5's disclosure of a major cybersecurity incident that led to significant drops in share price and questions about the timing and impact of the company's disclosures. Hagens Berman is investigating whether F5 timely reported the breach and its business implications, urging affected investors to come forward.

### Analyst Activity

**Target Signal:** BEARISH (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-17 | Morgan Stanley | $296 | $336 | -12% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-17 | Morgan Stanley | main | Equal-Weight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 16 ($0.00M) |
| Sells | 15 ($4.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 51.0% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 12.5% (-2.1%)
- Blackrock Inc.: 11.0% (-1.9%)
- Hotchkis & Wiley Cap: 8.3% (-7.5%)
- State Street Corpora: 5.5% (+1.7%)
- Geode Capital Manage: 3.0% (+1.7%)

### Key Risks

1. Insider selling cluster: $4.0M in recent transactions.
2. Elevated short interest (8.1%): bears positioning against stock.
3. Long-term trend broken: trading 10.1% below SMA200.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 2.07 elevated, pricing in significant growth expectations. Forward P/E 15.8x stretched relative to 8% growth. Quality metrics strong (ROE 21%, margin 22%). Analyst sentiment negative (1 target cuts vs 0 raises). Insider selling cluster ($4.0M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $14.9B |
| Beta | 0.99 |
| 52W Range | $223.76 - $346.00 |
| Short Interest | 8.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.07 |
| Forward P/E | 15.8 |
| Current P/E | 17.1 |
| YoY Growth | 7.8% |
| EPS Direction | FALLING |

### Technicals

MRS_20 deteriorating from 2.6% to 0.2% (-2.5% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 3.8pp (needs >4.0% for momentum thesis). MRS_5 (-0.1%) diverging from MRS_20 - short-term weakness emerging. Below SMA200 (0.90x), long-term trend not supportive. RSI neutral at 50. OFD pattern: +DUL (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 0.16% (CS: 41) | Neutral |
| RSI_14 | 50.3 | Neutral |
| MACD Histogram | 0.09 | Bullish |
| vs SMA20 | 0.996x | Below |
| vs SMA50 | 1.017x | Above |
| vs SMA200 | 0.899x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $256.63
- **Stop Loss:** $244.81 (4.6% risk)
- **Target:** $268.45 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 101
- **Position Value:** $25,919.63
- **Portfolio %:** 25.92%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 120% | L2 100% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (HIGH) | 1.20x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with stable risk appetite as 2026 trading begins. VIX at 14.51 (4th percentile) signals complacency while positive yield curve (+65bps) and moderate breadth (53.1%) support continuation. Focus on upcoming jobs data (Jan 9) and earnings season kickoff mid-January for directional catalysts.*

### Earnings

**Next:** 2026-01-27 (Est: $3.64)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $3.97 | $4.39 | +10.6% |
| 2025Q2 | $3.49 | $4.16 | +19.2% |
| 2025Q1 | $3.09 | $3.42 | +10.5% |
| 2024Q4 | $3.38 | $3.84 | +13.7% |

---
*RULE-based L3 | 2026-01-06 17:52 | MRS_20*